Results 171 to 180 of about 3,775,993 (302)

Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. [PDF]

ACR Open Rheumatol
Mease PJ, Nowak M, Choi J, Lehman T, Sreih A, Ho K, Middaugh N, Ogdie A.   +7 more
europepmc   +1 more source

The Examination of the Escape Phenomenon of the Disease Modifying Antirheumatic Drugs

, 2005
Yoichi Kawasaki, Masahiro Moriyama, Kazuhiko Shibata, Yutaka Gomita   +3 more
openalex   +2 more sources

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey. [PDF]

Ther Adv Musculoskelet Dis
Schreiber K, Graversgaard C, Parodis I, Agmon-Levin N, Aguilera S, Antovic A, Bertsias GK, Bini I, Bobirca A, Capela S, Cervera R, Costedoat-Chalumeau N, Dolhain R, Etomi O, Flint J, Fonseca JE, Fritsch-Stork R, Förger F, Giles I, Goulden B, Götestam Skorpen C, Gunnarsson I, Gupta L, Koksvik HS, Linde L, Lykke J, Meissner Y, Molto A, Moore L, Mosca M, Nelson-Piercy C, Perez-Garcia LF, Raio L, Rom AL, Rottenstreich A, Saleh M, Sciascia S, Strangfeld A, Svenungsson E, Tektonidou MG, Tincani A, Troldborg A, Vojinovic J, Voss A, Wallenius M, Zuniga-Serrano N, Andreoli L.   +46 more
europepmc   +1 more source

Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort [PDF]

, 2012
Ruben Tavares, Janet Pope, JEAN-LUC TREMBLAY, CARTER THORNE, VIVIAN P. BYKERK, JURIS LAZOVSKIS, KENNETH L.N. BLOCKA, MARY J. BELL, Diane Lacaille, Carol Hitchon, AVRIL A. FITZGERALD, WESLEY K. FIDLER, ARTHUR A.M. BOOKMAN, JAMES M. HENDERSON, DIANNE P. MOSHER, DALTON E. SHOLTER, Majed Khraishi, Boulos Haraoui, HONG CHEN, XIUYING LI, Andreas Laupacis, Gilles Boire, George Tomlinson, Claire Bombardier   +23 more
openalex   +1 more source

Risk of Serious Infections in Patients Treated With Biologic or Targeted-synthetic Disease Modifying Antirheumatic Drugs in Qatar. [PDF]

Immun Inflamm Dis
Sasi S, Hadi HA, Chaponda M, El Ajez R, Ataelmanan M, Khasawneh S, Saqallah H, Ali M, Abdulla N, Iqbal J, Omrani AS, Al Maslamani M, Al-Khal A.   +12 more
europepmc   +1 more source

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

Annals of the Rheumatic Diseases, 2017
K. Chatzidionysiou, S. Emamikia, J. Nam, S. Ramiro, J. Smolen, D. M. van der Heijde, M. Dougados, J. Bijlsma, G. Burmester, Marieke Scholte, R. V. van Vollenhoven, R. Landewé   +11 more
semanticscholar   +1 more source

Cardiovascular Outcomes of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Review of the Current Evidence. [PDF]

Cureus
Sunkara P, Garikipati NA, Nimmagadda R, Cherukuri AMK, Anne H, Chakilam R, Yadav D.   +6 more
europepmc   +1 more source

Initiation Patterns of Disease-Modifying Antirheumatic Drugs That Have Potential to Exacerbate Heart Failure. [PDF]

J Am Heart Assoc, 2023
Lee SB, D'Andrea E, Desai RJ.
europepmc   +1 more source

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis [PDF]

, 2005
Baeten, Dominique, BOOTS, AM, CANETE, JD, De Keyser, Filip, De Rycke, Leen, FOELL, D, Kruithof, Elli, ROTH, J, VANDOOREN, BERNARD, Veys, Eric   +9 more
core  

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

Annals of the Rheumatic Diseases, 2017
J. Nam, K. Takase-Minegishi, S. Ramiro, K. Chatzidionysiou, J. Smolen, D. M. van der Heijde, J. Bijlsma, G. Burmester, M. Dougados, M. Scholte-Voshaar, R. V. van Vollenhoven, R. Landewé   +11 more
semanticscholar   +1 more source